A multicentric prospective study in usual care: D-dimer and cardiovascular events in patients with atrial fibrillation

Camm, 2010, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278 Singer, 2009, The net clinical benefit of warfarin anticoagulation in atrial fibrillation, Ann Intern Med, 151, 297, 10.7326/0003-4819-151-5-200909010-00003 Singer, 2008, Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 133(6 Suppl.), 546S Antithrombotic therapy in atrial fibrillation, 2008, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 546S Connolly, 2006, Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, Lancet, 367, 1903, 10.1016/S0140-6736(06)68845-4 Connolly, 2009, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med, 360, 2066, 10.1056/NEJMoa0901301 Crandall, 2009, Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors, Pacing Clin Electrophysiol, 32, 981, 10.1111/j.1540-8159.2009.02427.x Fang, 2008, Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation, J Am Coll Cardiol, 51, 810, 10.1016/j.jacc.2007.09.065 Lip, 1995, Fibrin D-dimer: a useful clinical marker of thrombogenesis, Clin Sci, 89, 205, 10.1042/cs0890205 Lip, 1996, Fibrin D-dimers and -thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin, Circulation, 94, 425, 10.1161/01.CIR.94.3.425 Mahé, 2004, D-dimer can predict survival in patients with chronic atrial fibrillation, Blood Coagul Fibrinolysis, 15, 413, 10.1097/01.mbc.0000114440.81125.bd Ibebuogu, 2008, The D-dimer assay: a possible tool in the evaluation of atrial thrombosis, Can J Cardiol, 24, 517, 10.1016/S0828-282X(08)70629-9 Cohen, 2007, D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism?, Eur Heart J, 28, 2179, 10.1093/eurheartj/ehm170 Lowe, 2006, Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture, Br J Haematol, 133, 232, 10.1111/j.1365-2141.2006.06021.x Sadanaga, 2010, Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy, J Am Coll Cardiol, 55, 2225, 10.1016/j.jacc.2009.12.049 Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 2000, Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, Eur Heart J, 21, 1502, 10.1053/euhj.2000.2305 Harper, 2007, D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderly, Intern Med J, 37, 607, 10.1111/j.1445-5994.2007.01388.x Pieper, 2000, Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons, J Gerontol A Biol Sci Med Sci, 55, M649, 10.1093/gerona/55.11.M649 Li-Saw-Hee, 2000, Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation, Stroke, 31, 828, 10.1161/01.STR.31.4.828 Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946 Mahé, 2002, D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation, Thromb Res, 107, 1, 10.1016/S0049-3848(02)00184-6 Ohara, 2008, Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation, Int J Cardiol, 126, 316, 10.1016/j.ijcard.2007.06.020 Inoue, 2004, Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism, Chest, 126, 687, 10.1378/chest.126.3.687 Vene, 2003, High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy, Thromb Haemost, 90, 1163, 10.1160/TH03-06-0363 Nozawa, 2006, D-dimer level influences thromboembolic events in patients with atrial fibrillation, Int J Cardiol, 109, 59, 10.1016/j.ijcard.2005.05.049 Fuster, 1992, The pathogenesis of coronary artery disease and the acute coronary syndromes, N Engl J Med, 326, 242, 10.1056/NEJM199201233260406 Stroke Risk in Atrial Fibrillation Working Group, 2008, Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation, Stroke, 39, 1901, 10.1161/STROKEAHA.107.501825 Connolly, 2009, RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561